Experimental viral challenge in bronchiectasis to study the immunopathogenesis of exacerbations

Bronchiectasis is a chronic lung condition that affects over 200,000 individuals in the UK. The disease is characterised by progressive susceptibility to symptomatic flare-ups (exacerbations). These episodes are a major cause of morbidity and mortality with limited treatment options. Historically, bacteria have been deemed responsible for most…